Your browser doesn't support javascript.
loading
4-Fluoromethylphenidate: Fatal Intoxication Involving a Previously Unreported Novel Psychoactive Substance in the USA.
Shoff, Elisa N; Kahl, Joseph H; Hime, George W; Coburn, Marta; Boland, Diane M.
Afiliação
  • Shoff EN; Miami-Dade Medical Examiner Department, Toxicology Laboratory, 1851 NW 10th Ave., Miami, USA.
  • Kahl JH; Miami-Dade Medical Examiner Department, Toxicology Laboratory, 1851 NW 10th Ave., Miami, USA.
  • Hime GW; Miami-Dade Medical Examiner Department, Toxicology Laboratory, 1851 NW 10th Ave., Miami, USA.
  • Coburn M; District 20 Medical Examiner Department, 3838 Domestic Ave., Naples, USA.
  • Boland DM; Miami-Dade Medical Examiner Department, Toxicology Laboratory, 1851 NW 10th Ave., Miami, USA.
J Anal Toxicol ; 43(8): 666-672, 2019 Sep 10.
Article em En | MEDLINE | ID: mdl-31424072
The (±)-threo-4-fluoromethylphenidate (4F-MPH) is a fluorinated analog of the prescription central nervous system stimulant medication, methylphenidate. This novel psychoactive substance was first detected in drug paraphernalia at the Miami-Dade County Medical Examiner Department Toxicology Laboratory in 2016 but was not detected in a biological specimen until 2018. Limited literature is available on 4F-MPH, with predominate literature being published out of Europe, and no known toxicities reported in the USA. Post-mortem specimens were screened using both gas chromatography mass spectrometry and liquid chromatography ion trap mass spectrometry (LC-Ion Trap-MSn). In addition, a validated method for the quantification of 4F-MPH was developed using liquid chromatography-tandem mass spectrometry (LC-MS-MS), with a linear range of 0.01-0.500 mg/L and acceptable validation criteria including precision, bias, carry-over, linearity and endogenous/exogenous interferences. In addition to the detection of 4F-MPH, 3-methoxy-PCP, amphetamine, methamphetamine, 6-monoacetylmorphine, morphine, codeine and tetrahydrocannabinol were also identified in the decedent. A single source of blood was collected (femoral vein) and quantified in all blood tubes used for collection, with concentrations varying from 0.012 to 0.05 mg/L. Additional specimens available for screening included gastric contents and urine. An additional peak having the same targeted ions and transitions as 4F-MPH was identified in both the LC-Ion Trap-MSn screening procedure and the LC-MS-MS quantitative procedure. This peak suggests the presence of a structural isomer, possibly (±)-erythro-4-fluoromethylphenidate, which cannot be confirmed due to there being no available certified reference material. This case report presents the first time that 4F-MPH was detected in a decedent, as well as the first time 4F-MPH has been listed in the official cause of death of a decedent in Florida.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias / Toxicologia Forense / Estimulantes do Sistema Nervoso Central / Metilfenidato Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male Idioma: En Revista: J Anal Toxicol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias / Toxicologia Forense / Estimulantes do Sistema Nervoso Central / Metilfenidato Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male Idioma: En Revista: J Anal Toxicol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido